Contact
Please use this form to send email to PR contact of this press release:
Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies
TO:
Please use this form to send email to PR contact of this press release:
Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies
TO: